Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FFAR1 | O14842 | 2/20 | 0.67 |
| ▸ | FFAR4 | Q5NUL3 | 2/20 | 0.67 |
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.67 |
| ▸ | CAMK2A | Q9UQM7 | 1/20 | 0.52 |
| ▸ | LMNA | P02545 | 2/20 | 0.50 |
| ▸ | TSHR | P16473 | 1/20 | 0.50 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.50 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.50 |
| ▸ | GSTK1 | Q9Y2Q3 | 2/20 | 0.47 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.44 |
| ▸ | ENPEP | Q07075 | 1/20 | 0.42 |
| ▸ | FNTA | P49354 | 1/20 | 0.42 |
| ▸ | FNTB | P49356 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7639744 | 0.98 | FFAR1 (0.70) | FFAR1FFAR4GPR84CAMK2ALMNA | |
| SCHEMBL1134703 | 0.98 | FFAR1 (0.70) | FFAR1FFAR4GPR84CAMK2ALMNA | |
| SCHEMBL30678150 | 0.98 | FFAR1 (0.70) | FFAR1FFAR4GPR84CAMK2ALMNA | |
| SCHEMBL284713 | 0.98 | FFAR1 (0.70) | FFAR1FFAR4GPR84CAMK2ALMNA | |
| SCHEMBL7077765 | 0.98 | FFAR1 (0.70) | FFAR1FFAR4GPR84CAMK2ALMNA | |
| SCHEMBL1134705 | 0.98 | FFAR1 (0.70) | FFAR1FFAR4GPR84CAMK2ALMNA | |
| SCHEMBL284714 | 0.98 | FFAR1 (0.70) | FFAR1FFAR4GPR84CAMK2ALMNA | |
| SCHEMBL5956513 | 0.96 | FFAR1 (0.67) | FFAR1FFAR4GPR84CAMK2ALMNA | |
| SCHEMBL9359990 | 0.96 | FFAR1 (0.67) | FFAR1FFAR4GPR84CAMK2ALMNA | |
| SCHEMBL21461644 | 0.92 | FFAR1 (0.61) | FFAR1FFAR4GPR84CAMK2ALMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20060003948-A1 | Compositions that include a triterpene and a carrier | REGENTS OF THE UNIVERSITY OF MINNESOTA | 2006-01-05 | — | — | US | disclosed |
| WO-2005077377-A1 | COMPOSITIONS THAT INCLUDE A TRITERPENE AND A CARRIER | REGENTS OF THE UNIVERSITY OF MINNESOTA (US) | 2005-08-25 | — | — | WO | disclosed |
| US-20050014730-A1 | Anti-fungal formulation of triterpene and essential oil | REGENTS OF THE UNIVERSITY OF MINNESOTA | 2005-01-20 | — | — | US | disclosed |
| WO-2004089357-A2 | ANTI-FUNGAL FORMULATION OF TRITERPENE AND ESSENTIAL OIL | REGENTS OF THE UNIVERSITY OF MINNESOTA (US) | 2004-10-21 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050014730-A1 | Anti-fungal formulation of triterpene and essential oil | BET1, VRK1, VRK2 | FFAR1 2214/4885FFAR4 2405/4885GPR84 878/4885 |
| US-20060003948-A1 | Compositions that include a triterpene and a carrier | PGGT1B, BET1, CYP51A1 | FFAR1 3208/4885FFAR4 3424/4885GPR84 2131/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.